Skip to main content

Table 2 Baseline characteristics of the cohort

From: Peritoneal cytology predicting distant metastasis in uterine carcinosarcoma: machine learning model development and validation

Features

Training set(N=2404)

Test set(N=1030)

0 (N=1930)

1 (N=474)

0 (N=827)

1 (N=203)

Peritoneal cytology

 Negative

1562 (80.9%)

143 (30.2%)

686 (83.0)

60 (29.6)

 Suspicious

75 (3.9%)

21 (4.4%)

19 (2.3)

12 (5.9)

 Positive

293 (15.2%)

310 (65.4%)

122 (14.8)

131 (64.5)

Year of diagnosis

 2010-2013

595 (30.8%)

145 (30.6%)

253 (30.6)

73 (36.0)

 2014-2017

642 (33.3%)

171 (36.1%)

289 (34.9)

55 (27.1)

 2018-1021

693 (35.9%)

158 (33.3%)

285 (34.5)

75 (36.9)

Race

 Whites

1284 (66.5%)

308 (65%)

545 (65.9)

121 (59.6)

 Blacks

455 (23.6%)

117 (24.7%)

193 (23.3)

59 (29.1)

 Asian or Pacific Islander

178 (9.2%)

46 (9.7%)

79 (9.6)

21 (10.3)

 Native American/Alaska Native

13 (0.7%)

3 (0.6%)

10 (1.2)

2 (1.0)

Grade

 G1

76 (3.9%)

4 (0.8%)

22 (2.7)

3 (1.5)

 G2

91 (4.7%)

10 (2.1%)

36 (4.4)

6 (3.0)

 G3

1763 (91.3%)

460 (97%)

769 (93.0)

194 (95.6)

T-7th

 T1/T2

1517 (78.6%)

72 (15.2%)

657 (79.4%)

38 (18.7%)

 T3/T4

413 (21.4%)

402 (84.8%)

170 (20.6%)

165 (81.3%)

N-7th

 N0

1473 (76.3%)

255 (53.8%)

650 (78.6)

114 (56.2)

 N1

281 (14.6%)

120 (25.3%)

114 (13.8)

47 (23.2)

 N2

176 (9.1%)

99 (20.9%)

63 (7.6)

42 (20.7)

Marital status

 married

1002 (51.9%)

269 (56.8%)

403 (48.7%)

115 (56.7%)

 others

928 (48.1%)

205 (43.2%)

424 (51.3%)

88 (43.3%)

Median household income

 <50000

126 (6.5%)

39 (8.2%)

48 (5.8)

15 (7.4)

 50000-90000

1169 (60.6%)

291 (61.4%)

505 (61.1)

125 (61.6)

 >90000

635 (32.9%)

144 (30.4%)

274 (33.1)

63 (31.0)

Urban-rural coding

 An urban area with a population of 1 million or more

1137 (58.9%)

290 (61.2%)

506 (61.2)

119 (58.6)

 Metropolitan areas with a population of 25-1 million

444 (23%)

102 (21.5%)

203 (24.5)

48 (23.6)

 Metropolitan areas with a population of less than 250,000

144 (7.5%)

31 (6.5%)

45 (5.4)

14 (6.9)

 Non-metropolitan area and adjacent

120 (6.2%)

31 (6.5%)

47 (5.7)

15 (7.4)

 Non-metropolitan area and not adjacent

85 (4.4%)

20 (4.2%)

26 (3.1)

7 (3.4)

 Time from diagnosis to treatment (day)

28(15-42)

23(8-36)

28(16-42)

18(4-33.5)

 Tumor size

57(40-80)

75(55-100)

60(40-81.5)

75(50-110)

 Age

67(61-73)

65(59-72)

67(61-74)

65(58-72)